CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to identify and validate non-invasive drugs to prevent aneurysmal subarachnoid hemorrhage, a severe type of stroke. By repurposing existing medications, it seeks to enhance understanding of the disease pathways and improve treatment options for patients with unruptured intracranial aneurysms.
Rupture of intracranial aneurysms (IA) results in aneurysmal subarachnoid hemorrhage (aSAH), an often fatal type of stroke.
Invasive IA treatment to prevent aSAH is a high-risk procedure, limiting its use and leaving most IA patients untreated.
Thus, there is an urgent need for non-invasive drugs preventing aSAH, but these are lacking as our understanding of the causal disease pathways is poor.
The considerable female predominance in IA and aSAH suggests the existence of sex-specific regulation…
UNIVERSITAIR MEDISCH CENTRUM UTRECHT
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Netherlands, Utrecht
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
